India's Morepen Laboratories rises on license to make Hydroxychloroquine

Morepen Laboratories

21/04/2020 05:49

** Shares of drugmaker  MORL.NS  rise as much as 9.97% to 16
rupees, its biggest intra-day pct gain since April 8 
    ** Co says it received license to manufacture
Hydroxychloroquine at its Baddi Plant last week  urn:newsml:reuters.com:*:nFWN2C80QV
    ** India is world's largest producer of the drug; global
sales have soared, especially after it was touted as potential
treatment against COVID-19 by U.S. President Donald Trump
    ** Shares are down 6.43% this year, as of last close

 (Reporting by Philip George in Bengaluru)
 ((P.George@thomsonreuters.com; +91 8061822657; Reuters
Messaging: p.george@thomsonreuters.net))